Alzheimer's disease update: Using what we now know to help patients

Myron F. Weiner

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Treatments that can mildly improve cognitive symptoms and slow disease progression in patients with Alzheimer's disease include cholinesterase inhibitors, such as donepezil; vitamin E; and selegiline. Other agents can help control symptoms associated with dementia. For example, depression generally responds to the use of a selective serotonin reuptake inhibitor, which is given at roughly half the usual adult dosage. Patients with disturbed sleep may benefit from trazodone. Irritability, paranoid ideation, and delusions are more difficult to manage; however, antipsychotics (eg, haloperidol and risperidone) can be effective. The anticonvulsants carbamazepine and valproic acid can reduce irritability and agitation. The best approach to managing rummaging, hoarding, and wandering, which are not amenable to drug therapy, is to create a calm environment for the patient.

Original languageEnglish (US)
Pages (from-to)675-685
Number of pages11
JournalConsultant
Volume39
Issue number3
StatePublished - Mar 1999

Fingerprint

Alzheimer Disease
Trazodone
Selegiline
Neurobehavioral Manifestations
Delusions
Risperidone
Cholinesterase Inhibitors
Carbamazepine
Serotonin Uptake Inhibitors
Valproic Acid
Haloperidol
Vitamin E
Anticonvulsants
Antipsychotic Agents
Dementia
Disease Progression
Sleep
Depression
Drug Therapy
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Alzheimer's disease update : Using what we now know to help patients. / Weiner, Myron F.

In: Consultant, Vol. 39, No. 3, 03.1999, p. 675-685.

Research output: Contribution to journalArticle

Weiner, Myron F. / Alzheimer's disease update : Using what we now know to help patients. In: Consultant. 1999 ; Vol. 39, No. 3. pp. 675-685.
@article{eaa75435e7db440997770b3eabbcef02,
title = "Alzheimer's disease update: Using what we now know to help patients",
abstract = "Treatments that can mildly improve cognitive symptoms and slow disease progression in patients with Alzheimer's disease include cholinesterase inhibitors, such as donepezil; vitamin E; and selegiline. Other agents can help control symptoms associated with dementia. For example, depression generally responds to the use of a selective serotonin reuptake inhibitor, which is given at roughly half the usual adult dosage. Patients with disturbed sleep may benefit from trazodone. Irritability, paranoid ideation, and delusions are more difficult to manage; however, antipsychotics (eg, haloperidol and risperidone) can be effective. The anticonvulsants carbamazepine and valproic acid can reduce irritability and agitation. The best approach to managing rummaging, hoarding, and wandering, which are not amenable to drug therapy, is to create a calm environment for the patient.",
author = "Weiner, {Myron F.}",
year = "1999",
month = "3",
language = "English (US)",
volume = "39",
pages = "675--685",
journal = "Consultant",
issn = "0010-7069",
publisher = "Cliggott Publishing Co.",
number = "3",

}

TY - JOUR

T1 - Alzheimer's disease update

T2 - Using what we now know to help patients

AU - Weiner, Myron F.

PY - 1999/3

Y1 - 1999/3

N2 - Treatments that can mildly improve cognitive symptoms and slow disease progression in patients with Alzheimer's disease include cholinesterase inhibitors, such as donepezil; vitamin E; and selegiline. Other agents can help control symptoms associated with dementia. For example, depression generally responds to the use of a selective serotonin reuptake inhibitor, which is given at roughly half the usual adult dosage. Patients with disturbed sleep may benefit from trazodone. Irritability, paranoid ideation, and delusions are more difficult to manage; however, antipsychotics (eg, haloperidol and risperidone) can be effective. The anticonvulsants carbamazepine and valproic acid can reduce irritability and agitation. The best approach to managing rummaging, hoarding, and wandering, which are not amenable to drug therapy, is to create a calm environment for the patient.

AB - Treatments that can mildly improve cognitive symptoms and slow disease progression in patients with Alzheimer's disease include cholinesterase inhibitors, such as donepezil; vitamin E; and selegiline. Other agents can help control symptoms associated with dementia. For example, depression generally responds to the use of a selective serotonin reuptake inhibitor, which is given at roughly half the usual adult dosage. Patients with disturbed sleep may benefit from trazodone. Irritability, paranoid ideation, and delusions are more difficult to manage; however, antipsychotics (eg, haloperidol and risperidone) can be effective. The anticonvulsants carbamazepine and valproic acid can reduce irritability and agitation. The best approach to managing rummaging, hoarding, and wandering, which are not amenable to drug therapy, is to create a calm environment for the patient.

UR - http://www.scopus.com/inward/record.url?scp=0032827272&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032827272&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0032827272

VL - 39

SP - 675

EP - 685

JO - Consultant

JF - Consultant

SN - 0010-7069

IS - 3

ER -